Literature DB >> 34042188

Clinical assessment of a biophysical model for distinguishing tumor progression from radiation necrosis.

Ammoren E Dohm1, Tanner M Nickles2, Caroline E Miller2, Haley J Bowers2, Michael I Miga3, Albert Attia4,5, Michael D Chan1,6, Jared A Weis2,6.   

Abstract

PURPOSE: The efficacy of an imaging-driven mechanistic biophysical model of tumor growth for distinguishing radiation necrosis from tumor progression in patients with enhancing lesions following stereotactic radiosurgery (SRS) for brain metastasis is validated.
METHODS: We retrospectively assessed the model using 73 patients with 78 lesions and histologically confirmed radiation necrosis or tumor progression. Postcontrast T1-weighted MRI images were used to extract parameters for a mechanistic reaction-diffusion logistic growth model mechanically coupled to the surrounding tissue. The resulting model was then used to estimate mechanical stress fields, which were then compared with edema visualized on FLAIR imaging using DICE similarity coefficients. DICE, model, and standard radiographic morphometric analysis parameters were evaluated using a receiver operating characteristic (ROC) curve for prediction of radiation necrosis or tumor progression. Multivariate logistic regression models were then constructed using mechanistic model parameters or advanced radiomic features. An independent validation was performed to evaluate predictive performance.
RESULTS: Tumor cell proliferation rate resulted in ROC AUC = 0.86, 95% CI: 0.76-0.95, P < 0.0001, 74% sensitivity and 95% specificity) and DICE similarity coefficient associated with high stresses demonstrated an ROC AUC = 0.93, 95% CI: 0.86-0.99, P < 0.0001, 81% sensitivity and 95% specificity. In a multivariate logistic regression model using an independent validation dataset, mechanistic modeling parameters had an ROC AUC of 0.95, with 94% sensitivity and 96% specificity.
CONCLUSIONS: Imaging-driven biophysical modeling of tumor growth represents a novel method for accurately predicting clinically significant tumor behavior.
© 2021 American Association of Physicists in Medicine.

Entities:  

Keywords:  brain metastasis; computational model; radiation necrosis; stereotactic radiosurgery; tumor progression

Mesh:

Year:  2021        PMID: 34042188      PMCID: PMC8319112          DOI: 10.1002/mp.14999

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.506


  30 in total

1.  The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve.

Authors:  Neil J Perkins; Enrique F Schisterman
Journal:  Am J Epidemiol       Date:  2006-01-12       Impact factor: 4.897

2.  Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among 11C-Methionine-PET, FDG-PET, MR Permeability Imaging, and MRI-ADC-Preliminary Results.

Authors:  N Tomura; M Kokubun; T Saginoya; Y Mizuno; Y Kikuchi
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-15       Impact factor: 3.825

3.  A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases.

Authors:  May Tsao; Wei Xu; Arjun Sahgal
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

4.  New variants of a method of MRI scale standardization.

Authors:  L G Nyúl; J K Udupa; X Zhang
Journal:  IEEE Trans Med Imaging       Date:  2000-02       Impact factor: 10.048

5.  Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases.

Authors:  Deborah R Smith; Yandong Bian; Cheng-Chia Wu; Anurag Saraf; Cheng-Hung Tai; Tavish Nanda; Andrew Yaeh; Matthew E Lapa; Jacquelyn I S Andrews; Simon K Cheng; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Tony J C Wang
Journal:  J Neurooncol       Date:  2019-03-14       Impact factor: 4.130

6.  Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.

Authors:  Luke Peng; Vishwa Parekh; Peng Huang; Doris D Lin; Khadija Sheikh; Brock Baker; Talia Kirschbaum; Francesca Silvestri; Jessica Son; Adam Robinson; Ellen Huang; Heather Ames; Jimm Grimm; Linda Chen; Colette Shen; Michael Soike; Emory McTyre; Kristin Redmond; Michael Lim; Junghoon Lee; Michael A Jacobs; Lawrence Kleinberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-24       Impact factor: 7.038

7.  Predicting the Response of Breast Cancer to Neoadjuvant Therapy Using a Mechanically Coupled Reaction-Diffusion Model.

Authors:  Jared A Weis; Michael I Miga; Lori R Arlinghaus; Xia Li; Vandana Abramson; A Bapsi Chakravarthy; Praveen Pendyala; Thomas E Yankeelov
Journal:  Cancer Res       Date:  2015-09-02       Impact factor: 12.701

8.  Staged Stereotactic Radiosurgery for Large Brain Metastases: Local Control and Clinical Outcomes of a One-Two Punch Technique.

Authors:  Ammoren Dohm; Emory R McTyre; Catherine Okoukoni; Adrianna Henson; Christina K Cramer; Michael C LeCompte; Jimmy Ruiz; Michael T Munley; Shadi Qasem; Hui-Wen Lo; Fei Xing; Kounosuke Watabe; Adrian W Laxton; Stephen B Tatter; Michael D Chan
Journal:  Neurosurgery       Date:  2018-07-01       Impact factor: 4.654

9.  The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors.

Authors:  Thomas L Ellis; Matthew T Neal; Michael D Chan
Journal:  Int J Surg Oncol       Date:  2011-10-16

Review 10.  Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature.

Authors:  Philipp Kickingereder; Franziska Dorn; Tobias Blau; Matthias Schmidt; Martin Kocher; Norbert Galldiks; Maximilian I Ruge
Journal:  Radiat Oncol       Date:  2013-03-06       Impact factor: 3.481

View more
  1 in total

1.  Inducing Biomechanical Heterogeneity in Brain Tumor Modeling by MR Elastography: Effects on Tumor Growth, Vascular Density and Delivery of Therapeutics.

Authors:  Constantinos Harkos; Siri Fløgstad Svensson; Kyrre E Emblem; Triantafyllos Stylianopoulos
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.